Adoption of no-test and telehealth medication abortion care among independent abortion providers in response to COVID-19☆
Under a Creative Commons license
open access
Keywords
Abortion
Independent abortion clinics
COVID-19
Medication abortion
Telehealth
Practice changes
Mifepristone
USFDA REMS
Cited by (0)
- ☆
Declarations of interest: none.
© 2020 The Authors. Published by Elsevier Inc.